By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences today announced the closing of an $800,000 private placement.

The company sold units consisting of a total of 971,867 shares of restricted common stock and 485,937 warrants to purchase restricted common stock. Each unit consists of one share of restricted common stock and a warrant to purchase one-half share of common stock

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.